small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 84 results

Practice Area

Appellate & Critical Motions

Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing....Read more

Practice Area

Litigation/Trials

Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial....Read more

Practice Area

Corporate Governance

Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies....Read more

Insights & News 7,144 results

Webinar

|

22 JULY 2025

European Lending Market H1 2025 – CRE Data: What’s Happening in RE Debt Markets in Europe (2025 Update)

Join us for an insightful webinar during which Dr. Nicole Lux (of Bayes Business School) and Denis Moscovici and Christopher Puyraimond (both of IEIF) will ‘deep dive’ into key data sets emerging from commercial real estate lending market activity in H1 2025 across Western Europe and the Nordics, with a particular focus on France. Winston partner Aparna Sehgal, in conversation with our presenters and panellists, will look at trends and projections emerging from the information analysed, including what to expect for the rest of 2025. We’ll also look at European debt availability and explore the most pressing financing issues of the day. ...Read more

Sponsorship

|

July 16, 2025

Winston & Strawn Sponsors the Private Markets Secondaries Meeting East

Winston is proud to sponsor the Private Markets Secondaries Meeting East. This meeting brings together leading senior institutional investors and secondaries investment professionals to explore the latest trends and transactional opportunities in the secondary market....Read more

Competition Corner

|

July 8, 2025

|

10+ Min Read

Spotlight on Japan: Legal Trends in the Semiconductor Industry in the Japanese and U.S. Markets

Semiconductors are critical components that form the foundation of virtually all modern technologies and industries, including computers, smartphones, consumer electronics, automobiles, and medical devices. Their global importance continues to grow. This blog provides an overview of recent legal developments in the semiconductor markets of Japan and the United States.

View All Insights & News

Other Results 79 results

Law Glossary

Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?

The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here....Read more

Law Glossary

What Is the Purple Book?

Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product....Read more

Site Content

What Is Blockchain?

Blockchain is a technological system in which a digital list of records stored across a network. The network is a shared database comprised of a large number of computers. Blockchain is the primary technology for cryptocurrencies....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising